Cargando…

Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia

Introduction: Differential diagnostics of early-onset schizophrenia and autism spectrum disorders (ASD) are a problem of child psychiatry. The prognosis and relevant treatment are to a large degree determined by the correctness of diagnosis. We found earlier that leucocyte DNA of adult schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ershova, Elizaveta S., Veiko, Natalia N., Nikitina, Svetlana G., Balakireva, Elena E., Martynov, Andrey V., Chudakova, Julia M., Shmarina, Galina V., Kostyuk, Svetlana E., Salimova, Nataliya A., Veiko, Roman V., Porokhovnik, Lev N., Asanov, Aliy Yu, Izhevskaia, Vera L., Kutsev, Sergey I., Simashkova, Nataliya V., Kostyuk, Svetlana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693473/
https://www.ncbi.nlm.nih.gov/pubmed/36579513
http://dx.doi.org/10.3390/jpm12111796
_version_ 1784837551404613632
author Ershova, Elizaveta S.
Veiko, Natalia N.
Nikitina, Svetlana G.
Balakireva, Elena E.
Martynov, Andrey V.
Chudakova, Julia M.
Shmarina, Galina V.
Kostyuk, Svetlana E.
Salimova, Nataliya A.
Veiko, Roman V.
Porokhovnik, Lev N.
Asanov, Aliy Yu
Izhevskaia, Vera L.
Kutsev, Sergey I.
Simashkova, Nataliya V.
Kostyuk, Svetlana V.
author_facet Ershova, Elizaveta S.
Veiko, Natalia N.
Nikitina, Svetlana G.
Balakireva, Elena E.
Martynov, Andrey V.
Chudakova, Julia M.
Shmarina, Galina V.
Kostyuk, Svetlana E.
Salimova, Nataliya A.
Veiko, Roman V.
Porokhovnik, Lev N.
Asanov, Aliy Yu
Izhevskaia, Vera L.
Kutsev, Sergey I.
Simashkova, Nataliya V.
Kostyuk, Svetlana V.
author_sort Ershova, Elizaveta S.
collection PubMed
description Introduction: Differential diagnostics of early-onset schizophrenia and autism spectrum disorders (ASD) are a problem of child psychiatry. The prognosis and relevant treatment are to a large degree determined by the correctness of diagnosis. We found earlier that leucocyte DNA of adult schizophrenia patients contained significantly larger copy numbers of ribosomal repeats (rDNA) coding for rRNA, than DNA of mentally healthy controls. Aim: To compare the contents of ribosomal repeats in the leucocyte DNA of children with schizophrenia, children with ASD, and healthy age-matched controls to estimate the possibility of using this genetic trait in the differential diagnostics of the two types of disorders. Patients and methods: Blood samples of patients with infantile autism (A—F84.0 according to ICD-10, N = 75) and with childhood-onset schizophrenia (SZ—F20.8 according to ICD-10, N = 43) were obtained from the Child Psychiatry Department of the Mental Health Research Center. The healthy control blood samples (HC, N = 86) were taken from the Research Centre for Medical Genetics collection. The recruitment of cases was based on the clinical psychopathologic approach. DNA was extracted from blood leukocytes with organic solvents. Nonradioactive quantitative hybridization technique was applied for determining the abundance of ribosomal repeats in the genomes. Statistical processing was performed using StatPlus, Statgraphics and MedCalc. Findings: DNA derived from SZ cases contained 565 ± 163 rDNA copies, which is significantly (p < 10(−6)) higher than the rDNA content in ASD cases (405 ± 109 copies) and controls (403 ± 86 copies). The HC and A groups did not differ by rDNA copy number (p > 0.4). The genetic trait “rDNA copy number in patient’s genome” can potentially be applied as an additional marker in differential diagnostics of childhood-onset schizophrenia and autism spectrum disorders.
format Online
Article
Text
id pubmed-9693473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96934732022-11-26 Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia Ershova, Elizaveta S. Veiko, Natalia N. Nikitina, Svetlana G. Balakireva, Elena E. Martynov, Andrey V. Chudakova, Julia M. Shmarina, Galina V. Kostyuk, Svetlana E. Salimova, Nataliya A. Veiko, Roman V. Porokhovnik, Lev N. Asanov, Aliy Yu Izhevskaia, Vera L. Kutsev, Sergey I. Simashkova, Nataliya V. Kostyuk, Svetlana V. J Pers Med Article Introduction: Differential diagnostics of early-onset schizophrenia and autism spectrum disorders (ASD) are a problem of child psychiatry. The prognosis and relevant treatment are to a large degree determined by the correctness of diagnosis. We found earlier that leucocyte DNA of adult schizophrenia patients contained significantly larger copy numbers of ribosomal repeats (rDNA) coding for rRNA, than DNA of mentally healthy controls. Aim: To compare the contents of ribosomal repeats in the leucocyte DNA of children with schizophrenia, children with ASD, and healthy age-matched controls to estimate the possibility of using this genetic trait in the differential diagnostics of the two types of disorders. Patients and methods: Blood samples of patients with infantile autism (A—F84.0 according to ICD-10, N = 75) and with childhood-onset schizophrenia (SZ—F20.8 according to ICD-10, N = 43) were obtained from the Child Psychiatry Department of the Mental Health Research Center. The healthy control blood samples (HC, N = 86) were taken from the Research Centre for Medical Genetics collection. The recruitment of cases was based on the clinical psychopathologic approach. DNA was extracted from blood leukocytes with organic solvents. Nonradioactive quantitative hybridization technique was applied for determining the abundance of ribosomal repeats in the genomes. Statistical processing was performed using StatPlus, Statgraphics and MedCalc. Findings: DNA derived from SZ cases contained 565 ± 163 rDNA copies, which is significantly (p < 10(−6)) higher than the rDNA content in ASD cases (405 ± 109 copies) and controls (403 ± 86 copies). The HC and A groups did not differ by rDNA copy number (p > 0.4). The genetic trait “rDNA copy number in patient’s genome” can potentially be applied as an additional marker in differential diagnostics of childhood-onset schizophrenia and autism spectrum disorders. MDPI 2022-10-31 /pmc/articles/PMC9693473/ /pubmed/36579513 http://dx.doi.org/10.3390/jpm12111796 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ershova, Elizaveta S.
Veiko, Natalia N.
Nikitina, Svetlana G.
Balakireva, Elena E.
Martynov, Andrey V.
Chudakova, Julia M.
Shmarina, Galina V.
Kostyuk, Svetlana E.
Salimova, Nataliya A.
Veiko, Roman V.
Porokhovnik, Lev N.
Asanov, Aliy Yu
Izhevskaia, Vera L.
Kutsev, Sergey I.
Simashkova, Nataliya V.
Kostyuk, Svetlana V.
Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title_full Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title_fullStr Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title_full_unstemmed Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title_short Ribosomal DNA Abundance in the Patient’s Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia
title_sort ribosomal dna abundance in the patient’s genome as a feasible marker in differential diagnostics of autism and childhood-onset schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693473/
https://www.ncbi.nlm.nih.gov/pubmed/36579513
http://dx.doi.org/10.3390/jpm12111796
work_keys_str_mv AT ershovaelizavetas ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT veikonatalian ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT nikitinasvetlanag ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT balakirevaelenae ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT martynovandreyv ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT chudakovajuliam ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT shmarinagalinav ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT kostyuksvetlanae ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT salimovanataliyaa ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT veikoromanv ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT porokhovniklevn ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT asanovaliyyu ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT izhevskaiaveral ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT kutsevsergeyi ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT simashkovanataliyav ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia
AT kostyuksvetlanav ribosomaldnaabundanceinthepatientsgenomeasafeasiblemarkerindifferentialdiagnosticsofautismandchildhoodonsetschizophrenia